EPO Patents = 2

Forward Citations = 0

Loading Chart...

4 inventors (with patents filed for the assignee):

Brett A Tounge (5 out of 14 patents)

Shariff Bayoumy (5 out of 5 patents)

Lawrence C Kuo (5 out of 10 patents)

4. Scott L Dax (5 out of 50 patents)

5 patents: Sort by Forward Citations

1. 12162837 - Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same (2024-12-10),

2. 11319290 - Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same (2022-05-03),

3. 11198685 - Substituted ureas and methods of making and using same (2021-12-14),

4. 10836728 - Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same (2020-11-17),

5. 10683283 - Substituted ureas and methods of making and using same (2020-06-16),

Mebias Discovery, Inc. is a biotechnology company focused on drug discovery and development. We specialize in utilizing cutting-edge technologies and innovative approaches to identify and advance novel therapeutics for various diseases. Our research team is composed of experienced scientists and experts in the field, dedicated to making a positive impact on human health through groundbreaking discoveries.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#164 in Philadelphia, PA

#1,868 in Pennsylvania

#51,570 in US

Philadelphia, PA, United States of America

Mebias Discovery, Inc.

Forward Citations = 0

4 inventors:

Brett A Tounge (5 out of 14 patents)

Shariff Bayoumy (5 out of 5 patents)

Lawrence C Kuo (5 out of 10 patents)

4. Scott L Dax (5 out of 50 patents)

Please report any incorrect information to [email protected]

2 patents (EPO):

Please report any incorrect information to [email protected]